Q-omics provides the consensus-scored THSD8 profile across patient tissues and cancer cell-line models. Additionally, THSD8 RNA expression shows 6,475 significant protein co-abundance associations, with the highest sampling consensus in LSCC.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for THSD8 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with THSD8 in patient tissues and cancer cell lines. In patient samples, THSD8 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set. In cancer cell lines, THSD8 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BLOOD_Lymphoma.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	6,475	LSCC (2980)	view →
Function (mass-spec)	626	OV (269)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	6,705	BLOOD_Lymphoma (3240)	view →
Function (RNA)	2,614	BLOOD_Lymphoma (1016)	view →